Fleming is an innovative player in the Digital Health industry, established in 2020, and headquartered in Lithuania. The app stands out by offering rapid access to doctor appointments, symptom checking, treatment management, and medical data storage, all tailored to enhance patient-centric healthcare.
With its promise of connecting users to a doctor within two hours, regardless of location or time, Fleming is on a mission to simplify healthcare management. This comprehensive platform enables users to manage prescriptions and wearable data seamlessly, thus prioritizing their well-being efficiently.
Fleming's most recent funding was a €1.20M Seed Round investment in August 2021, reflecting investor confidence in its potential to disrupt traditional healthcare delivery. The lack of disclosed investors highlights an opportunity for parties interested in contributing to its growth. Overall, Fleming is well-positioned to benefit from the accelerating demand for digital health solutions.